These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 33801209)
41. Cyclin D1 regulates p27(Kip1) stability in B cells. Bustany S; Tchakarska G; Sola B Cell Signal; 2011 Jan; 23(1):171-9. PubMed ID: 20837141 [TBL] [Abstract][Full Text] [Related]
42. [Expression variation and significance of Skp2 and p27(kip1) during the proliferation of Jurkat cells]. Lu JX; Wang YC; Shen AG; Zhao YM; Sun CL; Zhang DM; Cheng C Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):330-4. PubMed ID: 18953829 [TBL] [Abstract][Full Text] [Related]
43. Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells. D'Alessio A; De Luca A; Maiello MR; Lamura L; Rachiglio AM; Napolitano M; Gallo M; Normanno N Breast Cancer Res Treat; 2010 Sep; 123(2):387-96. PubMed ID: 19946741 [TBL] [Abstract][Full Text] [Related]
44. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt. Yang H; Zhang Y; Zhao R; Wen YY; Fournier K; Wu HB; Yang HY; Diaz J; Laronga C; Lee MH Oncogene; 2006 Aug; 25(33):4585-94. PubMed ID: 16532026 [TBL] [Abstract][Full Text] [Related]
45. Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Kfir S; Ehrlich M; Goldshmid A; Liu X; Kloog Y; Henis YI Mol Cell Biol; 2005 Sep; 25(18):8239-50. PubMed ID: 16135812 [TBL] [Abstract][Full Text] [Related]
46. p27 Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353 [TBL] [Abstract][Full Text] [Related]
47. Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner. Cardoso F; Durbecq V; Laes JF; Badran B; Lagneaux L; Bex F; Desmedt C; Willard-Gallo K; Ross JS; Burny A; Piccart M; Sotiriou C Mol Cancer Ther; 2006 Dec; 5(12):3042-51. PubMed ID: 17148762 [TBL] [Abstract][Full Text] [Related]
49. Targeting p27Kip1 protein: its relevance in the therapy of human cancer. Borriello A; Bencivenga D; Criscuolo M; Caldarelli I; Cucciolla V; Tramontano A; Borgia A; Spina A; Oliva A; Naviglio S; Della Ragione F Expert Opin Ther Targets; 2011 Jun; 15(6):677-93. PubMed ID: 21355788 [TBL] [Abstract][Full Text] [Related]
50. Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung cancer. Lin TC; Tsai LH; Chou MC; Chen CY; Lee H Tumour Biol; 2016 Mar; 37(3):4017-23. PubMed ID: 26482622 [TBL] [Abstract][Full Text] [Related]
52. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865 [TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein. Brown KA; Roberts RL; Arteaga CL; Law BK Breast Cancer Res; 2004; 6(2):R130-9. PubMed ID: 14979923 [TBL] [Abstract][Full Text] [Related]
54. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Kamura T; Hara T; Matsumoto M; Ishida N; Okumura F; Hatakeyama S; Yoshida M; Nakayama K; Nakayama KI Nat Cell Biol; 2004 Dec; 6(12):1229-35. PubMed ID: 15531880 [TBL] [Abstract][Full Text] [Related]
55. P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo. Chen LC; Lee WS J Agric Food Chem; 2013 Mar; 61(11):2811-9. PubMed ID: 23448150 [TBL] [Abstract][Full Text] [Related]
56. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors. Chu S; McDonald T; Bhatia R Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561 [TBL] [Abstract][Full Text] [Related]
57. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Caballero OL; Resto V; Patturajan M; Meerzaman D; Guo MZ; Engles J; Yochem R; Ratovitski E; Sidransky D; Jen J Oncogene; 2002 May; 21(19):3003-10. PubMed ID: 12082530 [TBL] [Abstract][Full Text] [Related]
58. The prognostic of p27(kip1) in ovarian cancer: a meta-analysis. Lu M; Wang Y; Xu F; Xiang J; Chen D Arch Gynecol Obstet; 2016 Jan; 293(1):169-176. PubMed ID: 26198169 [TBL] [Abstract][Full Text] [Related]
59. Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip. Wang Z; Yu BW; Rahman KM; Ahmad F; Sarkar FH Mol Cancer Ther; 2008 Feb; 7(2):341-9. PubMed ID: 18281517 [TBL] [Abstract][Full Text] [Related]
60. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G; Hunter T; Ruoslahti E Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]